Continental Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,960
Closed -$1.28M 110
2017
Q3
$1.28M Buy
+20,960
New +$1.27M 0.29% 77
2016
Q1
Sell
-26,200
Closed -$1.32M 147
2015
Q4
$1.32M Hold
26,200
0.34% 87
2015
Q3
$1.24M Buy
+26,200
New +$1.39M 0.33% 89
2014
Q1
Sell
-73,360
Closed -$3.5M 143
2013
Q4
$3.5M Sell
73,360
-10,480
-13% -$479K 0.76% 31
2013
Q3
$3.81M Buy
83,840
+31,440
+60% +$1.44M 0.95% 24
2013
Q2
$2.32M Buy
+52,400
New +$2.34M 0.65% 48

Other funds holding MRK

Continental Advisors's MRK Position: Q3 2023 in Review

Continental Advisors sold out of Merck (MRK) in Q3 2023, closing a stake of 2,000 shares — an estimated $231K sold.

Continental Advisors first reported a position in MRK in Q2 2013 and held it in 41 quarters. The position peaked at $6.67M in Q4 2013. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Continental Advisors reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Continental Advisors sold 2,000 Merck shares in Q3 2023, an estimated $231K.
  • Continental Advisors first reported a position in Merck in Q2 2013 and held it in 41 quarters.
  • Continental Advisors's Merck position peaked at $6.67M in Q4 2013.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Continental Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.